BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 106 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $48,480,000 | -21.2% | 5,955,762 | -21.9% | 4.80% | -38.3% |
| Q4 2018 | $61,512,000 | +1.0% | 7,622,256 | -4.5% | 7.78% | -18.0% |
| Q3 2018 | $60,874,000 | +42.1% | 7,978,275 | +6.7% | 9.49% | +59.7% |
| Q2 2018 | $42,851,000 | -99.9% | 7,478,275 | 0.0% | 5.94% | +12.1% |
| Q1 2018 | $35,671,000,000 | +152784.5% | 7,478,275 | +57.4% | 5.30% | +33.1% |
| Q4 2017 | $23,332,000 | +171.9% | 4,751,883 | +190.2% | 3.98% | +138.5% |
| Q3 2017 | $8,580,000 | +10.7% | 1,637,332 | +33.7% | 1.67% | +4.8% |
| Q4 2016 | $7,754,000 | +142.5% | 1,225,000 | +69.0% | 1.59% | +95.5% |
| Q3 2016 | $3,197,000 | – | 725,000 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |